Project
I6T-MC-AMAN
Completed · 2018 until 2021
Brand Stephan, Krieger-Grübel Claudia, Sulz Michael, Smolders Jolijn
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Completed
Start Date
2018
End Date
2021
Financing
Industry
Brief description/objective
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients with Moderately to Severely Active Ulcerative Colitis LUCENT 1